The purpose of this study is to evaluate how well LY3985863 is tolerated and what side effects may occur in healthy Chinese participants. The study drug will be administered subcutaneously (SC) (under the skin).
Blood tests will be performed to investigate how the body processes the study drug and how the study drug affects the body.
Protocol Amendment History
4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2025-06-12; most recent amendment 2026-03-10.
Status change: Active, Not Recruiting → Completed2026-03-10
Status change: Recruiting → Active, Not Recruiting2025-11-19
Status change: Not Yet Recruiting → Recruiting2025-09-03